We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.
- Authors
Wick, Antje; Desjardins, Annick; Suarez, Cristina; Forsyth, Peter; Gueorguieva, Ivelina; Burkholder, Tiana; Cleverly, Ann Louise; Estrem, Shawn T.; Wang, Shuaicheng; Lahn, Michael M.; Guba, Susan C.; Capper, David; Rodon, Jordi
- Publication
Investigational New Drugs, 2020, Vol 38, Issue 5, p1570
- ISSN
0167-6997
- Publication type
Article
- DOI
10.1007/s10637-020-00910-9